» Articles » PMID: 34664991

The Importance of Cellular Immune Response to HIV: Implications for Antibody Production and Vaccine Design

Overview
Journal DNA Cell Biol
Publisher Mary Ann Liebert
Date 2021 Oct 19
PMID 34664991
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Despite many years from the discovery of human immunodeficiency virus (HIV), a prophylactic vaccine against HIV is still needed. The failure of most of the vaccine clinical trials in the field has different causes, mainly due by the difficulties to identify the correct antigen able to prime the optimal B cell lineage and then make the series of somatic mutations necessary to generate broadly neutralizing antibodies (bNAbs). B cells are responsible for the bNAbs production; however, their function is strongly influenced by the presence of a population of CD4 T lymphocytes, mainly present in the lymphoid organs, the T follicular helper cells (Tfh). In this review, the importance of the contribution of Tfh cells in HIV response is highlighted and future therapy perspectives based on these observations are described. The advanced technology available nowadays and the wide knowledge built over the past years for HIV may eventually create the best scenario for the generation of an effective vaccine.

Citing Articles

Bacterial vaginosis-driven changes in cervicovaginal immunity that expand the immunological hypothesis for increased HIV susceptibility.

MacLean F, Tsegaye A, Graham J, Swarts J, Vick S, Potchen N bioRxiv. 2024; .

PMID: 39005354 PMC: 11245000. DOI: 10.1101/2024.07.03.601916.


Strategies for HIV-1 suppression through key genes and cell therapy.

Sorokina A, Anchakova E, Dashinimaev E Front Med (Lausanne). 2023; 10:1259995.

PMID: 38093984 PMC: 10716291. DOI: 10.3389/fmed.2023.1259995.


Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV.

Wu S, Zou S, Ming F, Wu M, Guo W, Xing Z BMC Infect Dis. 2023; 23(1):34.

PMID: 36670363 PMC: 9854032. DOI: 10.1186/s12879-023-07982-x.


Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV.

Wu S, Zou S, Ming F, Wu M, Guo W, Xing Z Res Sq. 2022; .

PMID: 35794897 PMC: 9258300. DOI: 10.21203/rs.3.rs-1750225/v1.

References
1.
Hammarlund E, Lewis M, Hansen S, Strelow L, Nelson J, Sexton G . Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003; 9(9):1131-7. DOI: 10.1038/nm917. View

2.
Haynes B, Burton D, Mascola J . Multiple roles for HIV broadly neutralizing antibodies. Sci Transl Med. 2019; 11(516). PMC: 7171597. DOI: 10.1126/scitranslmed.aaz2686. View

3.
Yang H, Wallace Z, Dorrell L . Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction. Front Immunol. 2018; 9:2861. PMC: 6288286. DOI: 10.3389/fimmu.2018.02861. View

4.
Mbhele N, Chimukangara B, Gordon M . HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance. Int J Antimicrob Agents. 2021; 57(5):106343. DOI: 10.1016/j.ijantimicag.2021.106343. View

5.
Mu Z, Haynes B, Cain D . HIV mRNA Vaccines-Progress and Future Paths. Vaccines (Basel). 2021; 9(2). PMC: 7915550. DOI: 10.3390/vaccines9020134. View